EUVIMEDEUVIMED entdecken
Open Access

Genomic mapping of metastatic organotropism in lung adenocarcinoma

Harry B Lengel, Brooke Mastrogiacomo, James G Connolly, Kay See Tan, Yuan Liu, Cameron N Fick, Elizabeth G Dunne, Di He, Manendra B Lankadasari, Baby Anusha Satravada, Yichao Sun, Ritika Kundra und 15 weitere

Cancer Cell · 2023-05 · 41 (5) · 970-985.e3

DOI: 10.1016/j.ccell.2023.03.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2023-05. Verfasst von Harry B Lengel und 26 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We analyzed 2,532 lung adenocarcinomas (LUAD) to identify the clinicopathological and genomic features associated with metastasis, metastatic burden, organotropism, and metastasis-free survival. Patients who develop metastasis are younger and male, with primary tumors enriched in micropapillary or solid histological subtypes and with a higher mutational burden, chromosomal instability, and fraction of genome doublings. Inactivation of TP53, SMARCA4, and CDKN2A are correlated with a site-specific shorter time to metastasis. The APOBEC mutational signature is more prevalent among metastases, particularly liver lesions. Analyses of matched specimens show that oncogenic and actionable alterations are frequently shared between primary tumors and metastases, whereas copy number alterations of unknown significance are more often private to metastases. Only 4% of metastases harbor therapeutically actionable alterations undetected in their matched primaries. Key clinicopathological and genomic alterations in our cohort were externally validated. In summary, our analysis highlights the complexity of clinicopathological features and tumor genomics in LUAD organotropism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansMaleMutationDNA Copy Number VariationsGenomicsDNA HelicasesNuclear ProteinsTranscription Factors

Substanzen

SMARCA4 protein, humanDNA HelicasesNuclear ProteinsTranscription Factors

Autor:innen und Institutionen

  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense

Zitieren

APA

Lengel, H. B., Mastrogiacomo, B., Connolly, J. G., Tan, K. S., Liu, Y., Fick, C. N., Dunne, E. G., He, D., Lankadasari, M. B., Satravada, B. A., Sun, Y., Kundra, R., Fong, C., Smith, S., Riely, G. J., Rudin, C. M., Gomez, D. R., Solit, D. B., Berger, M. F., …, & Jones, D. R. (2023). Genomic mapping of metastatic organotropism in lung adenocarcinoma. Cancer Cell, 41(5), 970-985.e3. https://doi.org/10.1016/j.ccell.2023.03.018

Vancouver

Lengel HB, Mastrogiacomo B, Connolly JG, Tan KS, Liu Y, Fick CN, et al. Genomic mapping of metastatic organotropism in lung adenocarcinoma. Cancer Cell. 2023;41(5):970-985.e3. doi:10.1016/j.ccell.2023.03.018

BibTeX
@article{Lengel2023,
  author = {Lengel, Harry B and Mastrogiacomo, Brooke and Connolly, James G and Tan, Kay See and Liu, Yuan and Fick, Cameron N and Dunne, Elizabeth G and He, Di and Lankadasari, Manendra B and Satravada, Baby Anusha and Sun, Yichao and Kundra, Ritika and Fong, Chris and Smith, Shaleigh and Riely, Gregory J and Rudin, Charles M and Gomez, Daniel R and Solit, David B and Berger, Michael F and Li, Bob T and Mayo, Marty W and Matei, Irina and Lyden, David C and Adusumilli, Prasad S and Schultz, Nikolaus and Sanchez-Vega, Francisco and Jones, David R},
  title = {Genomic mapping of metastatic organotropism in lung adenocarcinoma},
  journal = {Cancer Cell},
  year = {2023},
  volume = {41},
  number = {5},
  pages = {970--985.e3},
  doi = {10.1016/j.ccell.2023.03.018}
}
Kostenlos starten →